Welltower stock (US95040Q1040): BMO Capital raises price target to $245

BMO Capital Markets lifted its price target on Welltower (NYSE: WELL) to $245 from $240, signaling confidence in the healthcare REIT's growth amid strong sector demand. Shares traded at $214.46 on May 8, 2026.

BMO Capital Markets raised its price target on Welltower to $245 from $240 in a note dated April 26, 2026, according to MarketBeat as of 05/08/2026. The adjustment reflects optimism about Welltower's portfolio of senior housing and healthcare properties. Welltower shares closed at $214.46, down 0.08%, on May 8, 2026, on the NYSE.

As of: 11.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Welltower Inc.
• Sector/industry: Healthcare REIT
• Headquarters/country: Toledo, Ohio, USA
• Core markets: US, Canada
• Key revenue drivers: Senior housing, medical offices
• Home exchange/listing venue: NYSE (WELL)
• Trading currency: USD

Welltower: core business model

Welltower Inc. operates as a real estate investment trust focused on healthcare infrastructure. The company owns properties serving the aging population, including senior living communities, medical office buildings, and post-acute care facilities. As an S&P 500 constituent, Welltower benefits from broad US market exposure, making it relevant for American investors tracking demographic trends.

Welltower's model emphasizes long-term leases with operators in the healthcare sector. This generates stable rental income, with properties concentrated in key US markets. The REIT structure requires distributing most taxable income as dividends, appealing to income-focused US portfolios.

Main revenue and product drivers for Welltower

Rent from senior housing and wellness communities forms the bulk of Welltower's revenue. Medical office buildings contribute through leases to physicians and outpatient services. These drivers align with rising US demand for healthcare real estate driven by an aging baby boomer population.

Post-acute facilities, including rehabilitation centers, add diversification. Welltower's portfolio spans over 1,600 buildings, primarily in the United States, supporting resilience for US investors amid healthcare spending growth.

Industry trends and competitive position

The US healthcare REIT sector benefits from demographic tailwinds, with seniors projected to drive demand through 2030. Welltower holds a leading position with its scale and focus on high-quality assets. Competitors like Ventas and Prologis face similar opportunities in real estate tied to healthcare.

Why Welltower matters for US investors

Listed on the NYSE, Welltower offers US investors direct exposure to healthcare real estate without property management hassles. Its S&P 500 status ensures liquidity and index inclusion, key for domestic portfolios. The company's US-centric assets tie performance to American economic and demographic shifts.

Conclusion

Welltower continues to navigate healthcare real estate dynamics with a robust portfolio. Recent analyst updates like BMO's price target hike underscore sector potential. US investors monitor demographic trends and interest rate impacts on REIT valuations as key factors.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.